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Introduction
Kartagener syndrome (KS) is a rare autosomal recessive 
disorder with an incidence of 1 per 20,000–30,000 live 
births (1). KS is a primary ciliary dyskinesia (PCD) 
characterized by situs inversus, paranasal sinusitis and 
bronchiectasis (2). Clinical manifestations of KS usually 
present during childhood and include chronic rhinitis due to 
pansinusitis, cough, wheeze and shortness of breath due to 
recurrent respiratory tract infections and bronchiectasis, and 
hearing problems due to otitis media (3,4). Recommended 
diagnostic investigations for KS include nasal nitric oxide 
measurement, ciliary biopsy with electron microscopy, 
functional ciliary beat/waveform analysis with high-speed 
videomicroscopy, and genetic testing (3).
Rout ine  t reatment  of  KS involves  da i ly  chest 
physiotherapy for airway clearance, antibiotics for acute 
respiratory exacerbations and vaccinations. Therapies 
considered on a case-by-case basis include chronic 
suppressive antibiotics, inhaled hyperosmolar agents (to 
promote cough clearance) and bronchodilators (3). Lung 
transplantation (LTx) is an option for end-stage KS, which 
results in respiratory insufficiency (5).
Here, we report the successful use of double LTx (DLTx) 
to treat a 49-year-old patient with end-stage KS.
Case presentation
A 49-year-old Han woman was admitted to Renmin 
Hospital of Wuhan University (Hubei,  China) on 
September 8, 2017. She had a ≥15 year history of chronic 
bronchiectasis with chest discomfort, productive cough and 
expectoration and had been treated with intranasal steroids 
and antibiotics for suspected diagnoses of chronic sinusitis 
and recurrent pneumonia. During the past year, her cough 
had exacerbated with the production of copious purulent 
sputum, and she underwent an 8-month course of therapy 
for suspected smear-negative pulmonary tuberculosis. The 
patient was a homemaker living in the countryside and had 
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never smoked cigarettes. There were no similar illnesses 
in her family. This study was conducted in full accordance 
with ethical principles (World Medical Association 
Declaration of Helsinki, and the Declaration of Istanbul) 
and was approved by ethics committee of Renmin Hospital 
of Wuhan University.
Physical examination revealed the following: weight, 
54 kg; body mass index, 18.6 kg/m2; blood pressure, 
91/60 mmHg; pulse rate, 109 beats/minute; respiratory rate, 
20 breaths/minute; temperature, 36.8 ℃; and arterial oxygen 
saturation (room air), 86%. There were coarse crackles and 
scattered rhonchi over both basal lung fields. The cardiac 
apex beat was palpable in the right fifth intercostal space 
along the midclavicular line, and heart sounds were best 
heard on the right side of the chest. Abdominal examination 
revealed a tympanitic note on percussion and no sign of 
fluid collection. The patient did not have any dyskinesia. 
Nervous system examination was unremarkable.
Laboratory investigations revealed normal values for 
hemoglobin (105 g/L), leukocyte count (5.97×109/L; 74% 
granulocytes and 16.4% lymphocytes), platelet count 
(130×109/L), and serum biochemistry tests. The patient 
had chronic airway colonization with Gram-negative 
bacteria but was negative for human immunodeficiency 
virus and mycobacterium tuberculosis (sputum test for acid 
fast bacilli). Arterial blood gas analysis revealed oxygen-
dependent respiratory failure and hypercapnia (PO2, 
52 mmHg; PCO2, 82 mmHg; base excess, 19 mmol/L) that 
required 24-hour oxygen support.
Anteroposterior chest radiography revealed a right-sided 
cardiac apex and aortic arch (Figure 1A). Echocardiography 
demonstrated dextrocardia and a pulmonary artery 
systolic pressure of 49 mmHg. High-resolution computed 
tomography (CT) of the chest showed bronchiectasis and 
fibrotic bands in both lower lung fields with no obvious 
lymph nodes in the mediastinum (Figure 1B). Abdominal 
CT showed a left-sided liver and inferior vena cava and a 
right-sided spleen, suggesting situs inversus (Figure 1C). 
Exome sequencing revealed mutations in the HEATR, 
DNAH1, DNAH5, DNAHI1, DNAH9, DNAI2 and 
DNAAF3 genes (Table 1). A diagnosis of KS was made based 
on the clinical findings (4,6).
The patient’s symptoms were partially relieved 
after several courses of antibiotics, oral steroids and 
bronchodilators but recurred after therapy was discontinued. 
The patient fulfilled the criteria for DLTx (5) and so was 
evaluated at our hospital for LTx. The measured/predicted 
recipient total lung capacity was 3.78/3.51 L (ratio: 1.08). 
After 6 months on the waiting list (March 31, 2018), a 
suitable donor was allocated by Chinese Donor Allocation 
System COTAS with the following characteristics: 32-year-
old male; weight, 58 kg; height, 156 cm; matching blood 
type; clear chest radiograph; no history of smoking, brain 
trauma or malignancy; and PaO2/FiO2 ratio of 563 mmHg.
The planned surgery was bilateral lung transplantation via 
bilateral anterolateral thoracotomy without the use of central 
extracorporeal membrane oxygenation (because our patient 
had a pulmonary artery systolic pressure of 28 mmHg). Left 
lung transplantation was performed first with an ischemic 
time of 132 min followed by right lung transplantation with 
an ischemic time of 224 min. An inadequate donor left atrial 
cuff due to technical errors at the time of procurement was 
evident during right lung transplantation. A partial patch 
repair with donor aorta remnant was performed, and the 
reconstruction was carried out using a 5-0 polypropylene 
running suture. Care was taken not to stretch or twist the 
pulmonary venous anastomosis (Figure 2A,B). All vascular 
anastomoses were carefully inspected to detect any tension, 
Figure 1 Imaging shows situs inversus and lung infection. (A) Anteroposterior chest X-ray showing dextrocardia; (B) chest CT showing 
bilateral lower lung bronchiectasis with infection; (C) abdominal CT showing situs inversus.
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Figure 2 The procedures of repairing and reconstructing an inadequate left cuff during lung transplantation. (A) A donor aorta patch was 
used to repair and reconstruct an inadequate left cuff during surgery; (B) left atrium after intraoperative anastomoses.
A B











DNAAF3 DNAAF3:NM_001256714:exon10:c.G1294A:p.D432N, DNAAF3:NM_001256715:exon10:c.G1093A:p.D365N, 
DNAAF3:NM_001256716:exon10:c.G93 1A:p.D31IN, DNAAF3:NM_178837:exon10:c.G1234A:p.D412N
kinking, narrowing or bleeding.
The patient was discharged to the intensive care unit and 
extubated on postoperative day 2. For immunosuppression, 
she received a standard triple regimen for 3 days (tacrolimus 
0.1 mg/kg PO bid, mycophenolate mofetil 1 g IV bid, and 
methylprednisolone 0.5 mg/kg IV qd) followed by oral 
prednisone from day 4 (0.5 mg/kg PO qd, tapering down 
by 5 mg/week to 0.25 mg/kg/day). Pseudomonas aeruginosa 
and methicillin-resistant Staphylococcus aureus, which were 
isolated from bronchoalveolar secretions obtained during 
bronchoscopy, were treated according to the antimicrobial 
resistance data and current guidelines. The patient 
recovered well and was discharged on postoperative day 18.
The pat ient  was  fo l lowed-up 21 months  a f ter 
transplantation. Her symptoms of cough and purulent 
sputum were relieved. At the last follow-up, the patient 
was doing well and was able to engage in her usual daily 
activities. Bronchoscopy was done 18 months after 
transplantation, which demonstrated a clear anastomotic 
airway without excessive granulation tissue, bronchomalacia, 
airway stenosis or fistula, and the anastomotic site showed no 
evidence of mucosal necrosis or sloughing (Figure 3A,B,C).
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Based on the physical examination and investigations, this 
patient was diagnosed to suffer from end-stage KS. Antibiotics, 
oral steroids and bronchodilators were administered which 
partially relieved the patient’s symptoms. However, because 
of the end-stage bronchiectasis secondary to KS, double 
lung transplantation (DLTx) was eventually performed with 
satisfactory outcomes up to 21 months follow-up.
iMDT discussion
Discussion among physicians from the Wuhan University 
of Renmin Hospital
Ciliary dysfunction is the underlying cause of KS (2). 
Impaired  c i l i a ry  mot i l i ty  dur ing  embryogenes i s 
predisposes to left-right laterality defects such as situs 
solitus (dextrocardia only) or situs inversus totalis (with 
transpositions of thoracic and abdominal organs). In 
addition to detrimental effects in the respiratory system, 
impaired ciliary motility can cause infertility secondary to 
sperm tail and fallopian tube dysfunction (3,6).
There are no curative treatments for KS. The main 
therapeutic measures for early-stage KS are daily chest 
physiotherapy, inhaled bronchodilators, vaccinations and 
antibiotics. For end-stage KS, LTx may be useful. The 
first heart and lung transplantation for KS (a 25-year-old 
woman with a history of recurrent pulmonary infection) 
was described in 1992 (7). Successful left LTx for KS was 
described 2 years later (8), but only a few additional case 
reports have been published since then, emphasizing the 
challenges of LTx in patients with KS. Up to 2016, 28 
patients with PCD or KS had undergone LTx in the USA, 
and their 1-year survival was comparable to that of patients 
with idiopathic pulmonary fibrosis, cystic fibrosis or chronic 
obstructive pulmonary disease (9). Surgical management 
of KS has been described for 2 cases in China, one treated 
with lobectomy and the other with LTx (10).
Very few case reports have described DLTx in patients 
with KS. The configuration and length of the main stem 
bronchi are inverted in patients with situs inversus, but 
no technical modifications for the different anatomic 
relationships were required in our case. The midline position 
of the left atrium and pulmonary artery allowed anastomoses 
with the recipient’s structures to be made as in patients with 
situs solitus. Previous publications have emphasized the 
potential anatomical conflict between the donor’s right lower 
lobe and the recipient’s dextrocardia, although lung volume 
reduction surgery was not necessary (8,11,12). However, in a 
previous case in China, right lower lobectomy was required 
during LTx because the volume of the right donor lung was 
larger than that of the recipient (10). In our patient, different 
bronchial angulation was not an obstacle, and airway 
continuity was reestablished with end-to-end anastomoses 
without the need for lung volume reduction (Figure 4).
There are some questions for further discussion.
Question 1: is there any difference between KS and 
normal patients in the procedure of DLTx?
Expert opinion 1: Dr. Daniel Kreisel
We have recently reported the case of double lung 
transplantation in a patient with Kartagener syndrome 
and described technical modifications to account for the 
anatomical variations in these patients (13). Since these 
patients have a long right mainstem bronchus and a short 
left mainstem bronchus, a right-sided double lumen 
endotracheal tube was used for our procedure that was 
placed in the anatomic right mainstem bronchus. Some 
technical modifications were required for the vascular 
anastomoses. The recipient left pulmonary artery was 
Figure 3 Bronchoscopy demonstrated a clear anastomotic airway.
Tracheal carina Right anastomotic airway Left anastomotic airway
A B C
1592 Wang et al. Lung transplantation for kartagener syndrome
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2020;12(4):1588-1594 | http://dx.doi.org/10.21037/jtd.2020.02.28
located anterior to the bronchus while the donor left 
pulmonary artery was located superior to the bronchus. 
An end-to-end anastomosis between donor and recipient 
pulmonary arteries was facilitated by mobilizing the 
recipient pulmonary artery and transposing it to an 
epibronchial position. In addition, we beveled the donor 
pulmonary artery to optimize the orientation of the end-to-
end anastomosis. We found that the right donor pulmonary 
artery needed to be adequately mobilized to account for a 
relatively short right pulmonary artery in the recipient. In 
our experience, no technical modifications were required for 
the bronchial or venous anastomoses. While reports exist 
that the size of the right lung graft needs to be reduced due 
to space limitations of the right chest cavity in the recipient, 
we did not find this necessary in our case.
Expert opinion 2: Dr. Jose Luis J. Danguilan
Yes, there is a difference in double lung transplantation in 
patients with Kartagener’s syndrome specially in those with 
anatomical variations like pulmonary situs inversus and 
dextrocardia (13). A right-sided double-lumen endotracheal 
tube was useful in the performance of pneumonectomy of 
the anatomic left lung with division of the short recipient 
left main bronchus (8,14).
A right lower lobectomy was required after implantation 
due to the right-sided heart interfering with lung 
expansion (14) although no technical modifications for the 
different anatomic relationships were necessary in a DLTx 
performed in a 46-year-old KS patient and discrepancies of 
the bronchial lumina were easily overcome (12).
Furthermore, a detailed preoperative anatomical study 
using multidetector row computed tomography (MDCT) 
with 3D reconstruction should be undertaken by the lung 
transplant team especially in patients with KS considering 
variations in anatomy (15).
Expert opinion 3: Dr. Michael Hsin
Since 1995, the Queen Mary Hospital Cardiothoracic Surgery 
Hospital Lung Transplant Program has performed two cases 
of double lung transplant for Kartagener’s syndrome, with one 
case in 2015 and the other case in 2019.The case from 2015 
was performed entirely with intraoperative ECMO support. 
For the more recent case, the left donor lung implantation 
was done without ECMO. When it came to the right side 
donor lung implantation, to achieve the necessary exposure 
the amount of retraction on the heart (because of dextrocardia) 
required intraoperative ECMO support.
For the case done in 2015, because of excessive size 
mismatch, lung volume reduction was required from 
the right middle lobe and the lingula. No lung volume 
reduction was needed for the case done in 2019. Similar to 
the current case report from the Wuhan group, there were 
no special modifications of the surgical technique for any of 
the anastomoses in either of the two cases from the Queen 
Mary Hospital. Both cases had uneventful operations and 
early post-operative recovery.
A recent case report from the St Louis group (13) did 
focus on the technical considerations in Kartagener’s 
syndrome. They pointed out the following:
(I) An initial attempt to use a standard left-sided 
double lumen endotracheal tube was unsatisfactory, 
and had to switch to using a right-sided double 
lumen endotracheal tube;
(II) For the recipient’s left pulmonary artery (PA) 
anastomosis, they noted that the recipient’s PA had a 
prebronchial position (i.e., anterior to the bronchus), 
whereas the donor PA had an epibronchial (superior 
to bronchus) location. The authors explained that 
they had to adequately mobilize the PA for both 
donor and recipient, and they had to divide the PA at 
a bevel for size and orientation matching.
Another earlier report from the Brigham and Women’s 
hospital described the use of an end-to side anastomosis to 
deal with the issue of left PA anastomosis (8). In order to 
Figure 4 Image of the reconstructed pulmonary vessels and bronchi obtained 5 months after surgery.
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avoid distortion of the PA, the recipient left PA was divided 
just beyond the origin of the truncus anterior, and the 
stump was oversewn. The donor PA was the anastomosed 
to the recipient at the origin of the truncus anterior. 
Although no kinking of the PA was encountered, the 
authors did mention that in postoperative angiogram, they 
noted variable pressure in the area of the anastomosis, 
suggesting turbulence of the pulmonary artery blood flow. 
Indeed, Gauthier et al. (13) commented that they did not 
use the end-to side anastomosis because of their concern 
regarding the risk of stasis in the PA arterial stump of the 
recipient PA.
Question 2: when the KS patient should consider about 
the surgery?
Expert opinion 1: Dr. Daniel Kreisel
Criteria to refer patients with Kartagener syndrome for 
lung transplantation generally resemble those for other 
patients, who suffer from bronchiectatic diseases such as 
cystic fibrosis. These criteria include forced expiratory 
volume in 1 second (FEV1) ≤25% predicted, hypercapnia, 
pulmonary hypertension and frequent exacerbations.
Expert opinion 2: Dr. Jose Luis J. Danguilan
As with other indications for lung transplantation, the 
patient with KS should be considered for transplantation 
if they have end-stage lung disease brought about by 
repeated infections and retained airway secretions from 
bronchiectasis for which maximal medical management and 
conventional lung resections would be futile. DLTx has 
been described for generalized bronchiectasis (16).
Expert opinion 3: Dr. Michael Hsin
Patients with Kartagener’s syndrome have primary 
ciliary dyskinesia (PCD), and the accumulation of airway 
secretions cause recurrent infections, eventually manifesting 
as bronchiectasis. In a minority of patients, this progresses 
to end-stage bronchiectasis. As pointed by the authors of 
this manuscript, there are only a handful of publications 
regarding lung transplantation in KS. Indeed, even for 
non-cystic fibrosis bronchiectasis, there is not a lot of 
published data available. However, the indicators of end-
stage lung disease in general bronchiectasis as outlined by 
Hayes et al can be useful as points of reference (9). These are: 
post-bronchodilator FEV1 <30%; exacerbation of pulmonary 
disease needing intensive care stay; increasing frequency of 
exacerbation needing intravenous antibiotics; refractory and/or 
recurrent pneumothorax; recurrent hemoptysis not controlled 
by embolization; other factors to consider include hypercarbia, 
rapidly declining lung function, and resting hypoxemia.
Question 3: what about the survival outcomes for the 
KS patients with DLTx?
Expert opinion 1: Dr. Daniel Kreisel
Lung transplantation for Kartagener syndrome is rare. A 
review of the United Network for Organ Sharing registry 
showed that 12 bilateral lung transplants have been 
performed between 1987 and 2015 (9). The 1-year and 
5-year survival rates after bilateral lung transplantation 
for Kartagener syndrome patients were 74% and 65%, 
respectively. Of note, no statistically significant differences 
existed between the survival rates after lung transplantation 
for Kartagener syndrome and lung transplantation for other 
conditions such as idiopathic pulmonary fibrosis, cystic 
fibrosis or chronic obstructive pulmonary disease.
Expert opinion 2: Dr. Jose Luis J. Danguilan
Since only a few patients with KS have undergone lung 
transplantation since 1987 (9), it would be difficult to 
accurately predict factors leading to long-term survival 
in this subset of patients. However, it is safe to say that 
lung transplantation markedly improves lung function and 
exercise tolerance but post-transplantation survival depends 
on the development of chronic lung allograft dysfunction 
(CLAD) (17).
Expert opinion 3: Dr. Michael Hsin
As stated in this manuscript, the study from Hayes et al. 
which queried the UNOS database between 1987-2015 on 
Kartagener’s syndrome, the long term outcome after LTx is 
comparable to the general LTx population (9). Specifically, 
when compared to idiopathic pulmonary fibrosis (IPF), 
cystic fibrosis (CF) and chronic obstructive pulmonary 
disease (COPD) recipients, using Cox proportional hazards 
regression, there were no differences in survival between KS 
group and these groups. Nor was there any significant survival 
advantage between KS group and these groups at one- year 
post lung transplant (9). Interestingly, the authors also looked 
at patients with PCD (impaired mucociliary clearance without 
situs inversus and chronic sinusitis). Whilst comparisons of 
overall survival between PCD and IPF, CF and COPD showed 
no difference, at one- year post transplant, there was survival 
advantage for CF and COPD relative to PCD.
Conclusions
In summary, we have reported the successful use of DLTx 
to treat a patient with end-stage KS and respiratory 
insufficiency. DLTx may be a feasible therapeutic option for 
controlling symptoms and achieving long term survival in 
patients with end-stage KS.
1594 Wang et al. Lung transplantation for kartagener syndrome
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